Syrrx
Latest round
- Series C
Last raised
- Jan 2001
Total raised
- $74M
Investors
- 8
About Syrrx
Syrrx is a pharmaceutical company specializing in innovative solutions for high-throughput structure determination and screening.Founded in San Diego, US, Syrrx focuses on delivering pharmaceutical solutions. The company was acquired by Takeda Pharmaceutical Company Limited in February 2005 for USD 270 mn.Syrrx specializes in delivering advanced pharmaceutical solutions, primarily focusing on high-throughput structure determination and high-throughput screening (HTS). Their offerings encompass a wide range of research tools aimed at elucidating molecular mechanisms, cellular functions, and immune responses. Core products include comprehensive research kits for DNA, RNA, and histone preparation, along with specialized assays like DNA bisulfite conversion and methylation quantification. Their clientele comprises leading research institutions and pharmaceutical companies engaged in genetics, cell biology, and disease pathology.Syrrx generates revenue through a B2B model, providing tailored pharmaceutical products and services to research institutions and pharmaceutical companies. Transactions typically involve direct sales of research kits, assays, and customized solutions, with structured pricing based on the specific products or packages selected by clients. These transactions may include long-term partnerships for ongoing research support, where clients subscribe to specific services or products based on their project requirements.Following its acquisition in February 2005, Syrrx's growth strategy may involve leveraging Takeda's resources to develop new products and enhance their market presence. Although specific upcoming products or expansion plans into new geographic regions were not detailed, the acquisition provides potential for increased investment in research and development initiatives.
Who invested in Syrrx
8 investors across 2 rounds
See all investors in Syrrx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syrrx
Who invested in Syrrx?
Syrrx has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syrrx raised?
Syrrx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Syrrx last raise money?
Syrrx's most recent round on record is a Series C, in Jan 2001.
What does Syrrx do?
Syrrx is a pharmaceutical company specializing in innovative solutions for high-throughput structure determination and screening.
Where is Syrrx headquartered?
Syrrx is headquartered in San Diego, US.
Which VCs invest in companies like Syrrx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Syrrx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Syrrx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.